142
C virus infection and membranoproliferative glomerulonephritis in Japan.J Am Soc
Nephrol. 1995;6:220-3.
38 Jefferson JA, Johnson RJ. Treatment of hepatitis C-associated glomerular disease.
Semin Nephrol. 2000;20:286-92.
39 D'Amico G, Fornasieri A. Cryoglobulinemic glomerulonephritis: a
membranoproliferative glomerulonephritis induced by hepatitis C virus.Am J Kidney
Dis. 1995;25:361-9.
40 Tarantino A, De Vecchi A, Montagnino G, Imbasciati E, Mihatsch MJ, Zollinger HU, et
al. Renal disease in essential mixed cryoglobulinaemia. Long-term follow-up of 44
patients.Q J Med. 1981;50:1-30.
41
Alric L, Plaisier E, Thebault S, Péron JM, Rostaing L, Pourrat J, et al. Influence of
antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.Am J Kidney
Dis. 2004;43:617-23.
42 Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL. High
prevalence of serological markers of autoimmunity in patients with chronic hepatitis
C. Hepatology. 1995;21:613-9.
43 Schiano TD, Te HS, Thomas RM, Hussain H, Bond K, Black M. Results of steroid-
based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.Am J
Gastroenterol. 2001;96:2984-91.
44 Muratori L, Lenzi M, Cataleta M, Giostra F, Cassani F, Ballardini G, et al. Interferon
therapy in liver/kidney microsomal antibody type 1-positive patients with chronic
hepatitis C.J Hepatol. 1994;21:199-203.
45 Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, et al. High
prevalence of thyroid autoantibodies in a prospective series of patients with chronic
hepatitis C before interferon therapy. Hepatology. 1993;18(2):253-7.
46 Mazziotti G, Sorvillo F, Stornaiuolo G, Rotondi M, Morisco F, Ruberto M, et al.
Temporal relationship between the appearance of thyroid autoantibodies and
development of destructive thyroiditis in patients undergoing treatment with two
different type-1 interferons for HCV-related chronic hepatitis: a prospective study. J
Endocrinol Invest. 2002 ;27:624-30.
47 Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D,. et al.
Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C
virus liver disease. Lancet. 1992;339:321-3.
48 Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence
for a cerebral effect of the hepatitis C virus. Lancet. 2001;358:38-9.
49 Heckmann JG, Kayser C, Heuss D, Manger B, Blum HE, Neundorfer B. Neurological
manifestations of chronic hepatitis C.J Neurol. 1999;246:486-91.
